LABORATORY FOR CARDIOVASCULAR BIOENGINEERING & THERAPEUTICS

Dr. Baker

Dr. Baker specializes in cardiovascular biology—specifically devices and interventional technologies to prevent atherosclerosis and restenosis. His research focuses on vascular mechanotransduction, or the study of cell and tissue responses to mechanical forces. Additionally, his lab works to advance vascular drug delivery and testing of drugs to be used for vessel regrowth and heart revascularization.

IN THE NEWS

  • August 2014: Subhamoy Das successfully completed his thesis defense and is now a Post-Doctoral Fellow!

  • July 2014: Jason Lee, Adrianne Shearer, and Peter Voyvodic's abstracts are accepted for 2014 BMES Conference Poster Presentations!

  • July 2014: Subhamoy Das, Victoria Le, and Anthony Monteforte's abstracts are accepted for 2014 BMES Conference Talks!

  • May 2014: Subhamoy Das wins first place for student competition presentation in Biomaterials Day at Texas A&M University!!

  • May 2014: Subhamoy Das and Anthony Monteforte selected for presentation finalists among candidates for Biomaterials Day at Texas A&M University!

  • April 2014: Dr. Baker receives grant from The Welch Foundation for Novel Drug Delivery Research!

  • April 2014: Peter Voyvodic receives SFB Poster Award for Cardiovascular track!

  • More news...

RESEARCH AREAS

  • Research

    Vascular Biology

    Our laboratory seeks to better understand the basic pathophysiologic processes that underlie atherosclerosis, stroke and other vascular disorders.

  • Research

    Therapeutics for Peripheral and Myocardial Ischemia

    Our laboratory seeks to understand why growth factor based therapies have failed to treat ischemia in patients and seeks to create novel therapeutics to increase growth factor effectiveness in this context.

  • ResearchMechanobiology

    Our lab is developing novel devices and molecular techniques for studying how vascular cells sense and respond to mechanical forces.

  • Research

    Implanted Cardiovascular Devices

    Our group works to understand the fundamental mechanisms that control the biological response to cardiovascular devices such as endovascular stents with the ultimate goal of designing more effective interventions for cardiovascular disease.